Canonical ID: NK-ASgVBbQmGzTwaKx68gkTcH · Entity type: Company (reference)
| Property | Value | Lang | Source dataset | Source ID | First seen | ||
|---|---|---|---|---|---|---|---|
Company:alias | 苏州小栗医药科技有限公司 | eng | ext_us_ofac_press_releases | NK-ASgVBbQmGzTwaKx68gkTcH | |||
Company:country | cn | eng | ext_us_ofac_press_releases | NK-ASgVBbQmGzTwaKx68gkTcH | |||
Company:id | 021befa24c55f05e83891b722a7d15e6b1dd0ed5 | ext_us_ofac_press_releases | NK-ASgVBbQmGzTwaKx68gkTcH | ||||
Company:name | Suzhou Xiaoli Pharmatech Co., Ltd | eng | ext_us_ofac_press_releases | NK-ASgVBbQmGzTwaKx68gkTcH | |||
Company:sourceUrl | https://home.treasury.gov/news/press-releases/jy1413 | eng | ext_us_ofac_press_releases | NK-ASgVBbQmGzTwaKx68gkTcH | |||